Regional Deposition in Generic Dry Powder Inhalers

Nanopharm investigate regional deposition and simulated inhaled pharmacokinetic profiles of generic dry powder inhalers.

Alternative regulatory path for generic Respiratory Products

Explore Nanopharm’s SmartTrack, an alternative solution for FDA approval of generic inhalation drug delivery products.

Challenges in OINDPs Achieving Q3 Equivalence

Nanopharm review the bioequivalence challenges for OINDPs by achieving Q3 structural equivalence.